Search results
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoMerck has reported that its Phase III KEYNOTE-522 clinical trial of KEYTRUDA to treat high-risk,...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 1 day agoFinnish biotechnology company TILT Biotherapeutics has announced results from a Phase I clinical ...
IGC Pharma enrols two subjects in Alzheimer’s therapy trial at Neurostudies
Clinical Trials Arena via Yahoo Finance· 10 hours agoIn January, IGC Pharma announced the dosing of the first patient at ClinCloud, a new clinical...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 1 day agoPhase 2, Proof-of-Concept X-NOVA Study” May 29, 2024 at 11:15 am to 1 pm ET in Salon 4 The Company’s presentations summarize clinical ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 9 hours agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating ...
GeoVax to Present at BIO International Convention 2024
Digital Journal· 7 hours agoAbout GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for solid tumor cancers and many of the ...
Ikena Oncology Discontinues IK-930 Program And Cuts Workforce, Analyst Calls It 'Disappointing' -...
Benzinga· 49 minutes agoConcurrently, Ikena is evaluating strategic options for the company and its development pipeline. The company said that based on a review of clinical data ...
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...
WTNH-TV New Haven· 6 days agoData will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting....
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 5 days ago(NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing...
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
Morning Times· 2 days agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase< ...